ClinicalTrials.gov record
Suspended Early Phase 1 Interventional

Effect of Kava on Anxiety and Stress in Cancer Survivors

ClinicalTrials.gov ID: NCT06213298

Public ClinicalTrials.gov record NCT06213298. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 2:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06213298
Recruitment status
Suspended
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Masonic Cancer Center, University of Minnesota
Other
Enrollment
43 participants

Conditions and interventions

Interventions

  • Kava Drug
  • Placebo Dietary Supplement

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2024
Primary completion
Nov 29, 2027
Completion
Oct 31, 2028
Last update posted
Feb 10, 2026

2024 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Masonic Cancer Center Minneapolis Minnesota 55455

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06213298, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2026 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06213298 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →